$2.7M
Cost savings from supplier diversification and freight optimization
Industry: Life Sciences
Service: Cost and Value Engineering
Service: Manufacturing
Service: Procurement
Service: Supply Chain
A global manufacturer of insulin pen needles, syringes, and complementary diabetes care products serving human and veterinary applications.
The client faced significant supply chain vulnerabilities and operational inefficiencies due to overreliance on a single supplier and fragmented processes across procurement, production, and distribution.
EFESO’s end-to-end optimization program strengthened the client’s supply chain resilience, reduced costs, and improved operational performance across production, logistics, and sourcing.
$2.7M
Cost savings from supplier diversification and freight optimization
30%
Productivity increase in production operations
22%
Reduction in finished goods inventory
+250
SKUs to sourced from 4 different countries and predominately marketed in North America
EFESO conducted a comprehensive operational assessment to pinpoint inefficiencies and build a resilient, cost-optimized supply network through five key workstreams:
Production Efficiency Improvement
Freight Cost Optimization
Inventory Management Enhancement
Supplier Diversification & Cost Reduction
Sales, Inventory, and Operations Planning (SIOP)